Cargando…

Proteomic Profiling of Acute Promyelocytic Leukemia Identifies Two Protein Signatures Associated with Relapse

PURPOSE: Acute promyelocytic leukemia (APL) is the most prognostically favorable subtype of Acute myeloid leukemia (AML). Defining the features that allow identification of APL patients likely to relapse after therapy remains challenging. EXPERIMENTAL DESIGN: Proteomic profiling is performed on 20 n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hoff, Fieke W., Hu, Chenyue W., Qutub, Amina A., Qiu, Yihua, Hornbaker, Marisa J., Bueso‐Ramos, Carlos, Abbas, Hussein A., Post, Sean M., de Bont, Eveline S. J. M., Kornblau, Steven M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6635093/ https://www.ncbi.nlm.nih.gov/pubmed/30650251 http://dx.doi.org/10.1002/prca.201800133

Ejemplares similares

Mycoplasma contamination of leukemic cell lines alters protein expression determined by reverse phase protein arrays
por: Hoff, Fieke W., et al.
Publicado: (2018)

Clinical relevance of proteomic profiling in de novo pediatric acute myeloid leukemia: a Children’s Oncology Group study
por: Hoff, Fieke W., et al.
Publicado: (2022)

AML-343: Loss of H3K27 Methylation Identifies Poor Outcomes in Adult-Onset Acute Lymphoblastic and Myeloid Leukemia
por: Dijk, Anneke van, et al.
Publicado: (2020)

Progeny Clustering: A Method to Identify Biological Phenotypes
por: Hu, Chenyue W., et al.
Publicado: (2015)

2180: hnRNP K overexpression drives acute myeloid leukemia emergence and progression
por: Hornbaker, Marisa, et al.
Publicado: (2018)

Protein profiling by reverse phase protein array (RPPA) in classical hairy cell leukemia (HCL) and HCL‐variant
por: Hoff, Fieke W., et al.
Publicado: (2022)

Decoupling Lineage-Associated Genes in Acute Myeloid Leukemia Reveals Inflammatory and Metabolic Signatures Associated With Outcomes
por: Abbas, Hussein A., et al.
Publicado: (2021)

Prognostication of DNA Damage Response Protein Expression Patterns in Chronic Lymphocytic Leukemia
por: Griffen, Ti’ara L., et al.
Publicado: (2023)

Proteomic profiling based classification of CLL provides prognostication for modern therapy and identifies novel therapeutic targets
por: Griffen, Ti’ara L., et al.
Publicado: (2022)

Comprehensive mutational analysis of primary and relapse acute promyelocytic leukemia
por: Madan, V, et al.
Publicado: (2016)

LGALS3 is connected to CD74 in a previously unknown protein network that is associated with poor survival in patients with AML
por: Ruvolo, Peter P., et al.
Publicado: (2019)

Erratum: Comprehensive mutational analysis of primary and relapse acute promyelocytic leukemia
por: Madan, V, et al.
Publicado: (2016)

DNA Damage Response−Related Proteins Are Prognostic for Outcome in Both Adult and Pediatric Acute Myelogenous Leukemia Patients: Samples from Adults and from Children Enrolled in a Children’s Oncology Group Study
por: Hubner, Stefan E., et al.
Publicado: (2023)

Shrinkage Clustering: a fast and size-constrained clustering algorithm for biomedical applications
por: Hu, Chenyue W., et al.
Publicado: (2018)

Leptomeningeal Relapse of Acute Promyelocytic Leukemia
por: Hadid, Tarik, et al.
Publicado: (2014)

Reverse Phase Protein Array Profiling Identifies Recurrent Protein Expression Patterns of DNA Damage-Related Proteins across Acute and Chronic Leukemia: Samples from Adults and the Children’s Oncology Group
por: Hoff, Fieke W., et al.
Publicado: (2023)

Proteomic Profiling Identifies Distinct Protein Patterns in Acute Myelogenous Leukemia CD34+CD38- Stem-Like Cells
por: Kornblau, Steven M., et al.
Publicado: (2013)

Peptide microarray of pediatric acute myeloid leukemia is related to relapse and reveals involvement of DNA damage response and repair
por: Mahmud, Hasan, et al.
Publicado: (2019)

Central Nervous System Double Relapse of Acute Promyelocytic Leukemia and Acute Myelomonocytic Leukemia
por: Stanko, Laura M., et al.
Publicado: (2019)

Dual origin of relapses in retinoic-acid resistant acute promyelocytic leukemia
por: Lehmann-Che, Jacqueline, et al.
Publicado: (2018)

Treatment for relapsed acute promyelocytic leukemia: what is the best post-remission treatment?
por: Min, Gi-June, et al.
Publicado: (2022)

Loss of H3K27 methylation identifies poor outcomes in adult-onset acute leukemia
por: van Dijk, A. D., et al.
Publicado: (2021)

Evolution‐informed modeling improves outcome prediction for cancers
por: Liu, Li, et al.
Publicado: (2016)

Genetic and Epigenetic Signatures in Acute Promyelocytic Leukemia Treatment and Molecular Remission
por: Borutinskaitė, Veronika, et al.
Publicado: (2022)

Long-term survival in a patient with acute promyelocytic leukemia with isolated meningeal relapse
por: Kim, Se Hyung, et al.
Publicado: (2010)

Acute promyelocytic leukemia relapsing into acute myeloid leukemia-M2 with normal cytogenetics
por: Sahoo, Ranjit Kumar, et al.
Publicado: (2013)

Very Late Relapse of Acute Promyelocytic Leukemia 17 Years after Continuous Remission
por: Sakurai, Masatoshi, et al.
Publicado: (2018)

Acute Myeloid Leukemia Acquiring Promyelocytic Leukemia-Retinoic Acid Receptor Alpha at Relapse
por: Gupta, Varsha, et al.
Publicado: (2019)

Molecular and hematologic relapses in adult patients with acute promyelocytic leukemia: a cohort study
por: Azevedo, Ilana de França, et al.
Publicado: (2017)

Can kinomics and proteomics bridge the gap between pediatric cancers and newly designed kinase inhibitors?
por: van der Sligte, Naomi E., et al.
Publicado: (2015)

Molecular Drivers of Myelodysplastic Neoplasms (MDS)—Classification and Prognostic Relevance
por: Hoff, Fieke W., et al.
Publicado: (2023)

Phase I Trial of Lithium and Tretinoin for Treatment of Relapsed and Refractory Non-promyelocytic Acute Myeloid Leukemia
por: Ueda, Masumi, et al.
Publicado: (2020)

Meningeal Relapse in a Patient with Acute Promyelocytic Leukemia: A Case Report and Review of the Literature
por: Bae, Sung Hwa, et al.
Publicado: (2004)

HIF factors cooperate with PML-RARα to promote acute promyelocytic leukemia progression and relapse
por: Coltella, Nadia, et al.
Publicado: (2014)

Absolute quantification of the pretreatment PML-RARA transcript defines the relapse risk in acute promyelocytic leukemia
por: Albano, Francesco, et al.
Publicado: (2015)

Evolution of a FLT3-TKD mutated subclone at meningeal relapse in acute promyelocytic leukemia
por: Bochtler, Tilmann, et al.
Publicado: (2016)

A Rare Case of Relapsed Pediatric Acute Promyelocytic Leukemia with Skin Involvement by Myeloid Sarcoma
por: Araújo, Nathalia Silva, et al.
Publicado: (2018)

Management of relapse in acute promyelocytic leukaemia treated with up‐front arsenic trioxide‐based regimens
por: Fouzia, N. A., et al.
Publicado: (2020)

Treatment of Central Nervous System Relapse in Acute Promyelocytic Leukemia by Venetoclax: A Case Report
por: Zhang, Xuzhao, et al.
Publicado: (2021)

An Atypical Presentation of Relapsing Polychondritis Manifesting As Acute Angle Closure
por: Cape, Hays, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_t14nskcc4brnqt46e7of2b8m48